Cancer Advances
  • Home
  • About
  • Our Science
    • Our Target
    • Our Product
  • News & Events
  • Contact
Select Page

April 9, 2021 – Cancer Advances, Inc. Announces Minisymposium Presentation at AACR

Apr 13, 2021 | Press Releases

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse...

Recent Posts

  • April 9, 2021 – Cancer Advances, Inc. Announces Minisymposium Presentation at AACR
  • March 18, 2021 – Cancer Advances, Inc. Announces Abstract at AACR
  • November 11, 2019 – Cancer Advances, Inc. announces a new publication “Vaccine Against Gastrin, a Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases” in the American Journal of Physiology—Gastrointestinal and Liver Physiology
  • November 11, 2019 – Cancer Advances, Inc. announces new publication: “Gastrin Vaccine Improves Response to Immune Checkpoint Antibody in Murine Pancreatic Cancer by Altering the Tumor Microenvironment”, in the journal Cancer Immunology, Immunotherapy

Recent Comments

    © 2020 Cancer Advances, Inc. All rights reserved.